Axl/Gas6 pathway positively regulates FLT3 activation in human natural killer cell development

No abstract is available for this paper.

• Publication year

  2013

• Venue

  European Journal of Immunology

• Publication date

  2013-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/eji.201243116PMID 23722894PMCID PMC3829002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell development.

  2009cited by this paper
• Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3.

  2009cited by this paper
• Gas6 and protein S

  2006cited by this paper
• Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases.

  2006cited by this paper
• Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases

  2006cited by this paper
• Normal and oncogenic FLT3.

  2004cited by this paper
• Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells.

  2000cited by this paper
• The First Laminin G-Type Domain in the SHBG-Like Region of Protein S Contains Residues Essential for Activation of the Receptor Tyrosine Kinase Sky

  2000cited by this paper
• Flt3 Ligand Promotes the Generation of a Distinct CD34+Human Natural Killer Cell Progenitor That Responds to Interleukin-15

  1998cited by this paper
• Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15.

  1998cited by this paper
• Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts

  1997cited by this paper
• Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells.

  1996cited by this paper
• Reevaluation of the roles of protein S and Gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3.

  1995cited by this paper
• Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors.

  1995cited by this paper
• Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs

  1994cited by this paper
• The flt3 ligand: a hematopoietic stem cell factor whose activities are distinct from steel factor.

  1994cited by this paper
• Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells.

  1993cited by this paper
• Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.

  1981cited by this paper

• Targeting Oncogenic Activity and Signalling of Mutant Receptor Tyrosine Kinase FLT3

  2025cites this paper
• Therapeutic Landscape of AXL Receptor Kinase in Triple Negative Breast Cancer.

  2023cites this paper
• Imputation of Human Primary Osteoblast Single Cell RNA-Seq Data Identified Three Novel Osteoblastic Subtypes

  2022cites this paper
• Mechanisms of venetoclax resistance and solutions

  2022cites this paper
• Targeting AXL kinase sensitizes leukemic stem and progenitor cells to venetoclax treatment in acute myeloid leukemia

  2021cites this paper
• Targeting c-Met and AXL Crosstalk for the Treatment of Hepatocellular Carcinoma

  2021cites this paper
• Immune Evasion Mechanism and AXL

  2021cites this paper
• AXL Is a Key Factor for Cell Plasticity and Promotes Metastasis in Pancreatic Cancer

  2020cites this paper
• Novel Targets in Melanoma: Intralesional and Combination Therapy to Manipulate the Immune Response.

  2020cites this paper
• A systematic dissection of human primary osteoblasts in vivo at single-cell resolution

  2020cites this paper
• Novel Approaches to Target Mutant FLT3 Leukaemia

  2020influential citation
• ssExpression level of GAS6-mRNA influences the prognosis of acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation

  2019cites this paper
• Chapter 9 – Development and Function of Natural Killer Cells and Its Importance in Cancer Immunotherapy

  2018cites this paper
• Does Axl have potential as a therapeutic target in pancreatic cancer?

  2018cites this paper
• CAR T-cells targeting FLT3 have potent activity against FLT3−ITD+ AML and act synergistically with the FLT3-inhibitor crenolanib

  2018cites this paper
• Microenvironnement médullaire et résistance des LAM FLT3-ITD aux inhibiteurs de tyrosine kinase : Rôle pivot du récepteur TAM AXL

  2017influential citation
• Mechanistic roles of autophagy in hematopoietic differentiation

  2017cites this paper
• Axl and Mer Receptor Tyrosine Kinases: Distinct and Nonoverlapping Roles in Inflammation and Cancer?

  2016cites this paper
• Gene of the month: Axl

  2016cites this paper
• Analysis of receptor tyrosine kinase genetics identifies two novel risk loci in GAS6 and PROS1 in Behçet’s disease

  2016cites this paper
• TAM receptor signaling in immune homeostasis.

  2015cites this paper
• Axl RTK and microRNAs in urogenital cancers

  2015cites this paper
• Receptor tyrosine kinase Axl is required for resistance of leukemic cells to FLT3-targeted therapy in acute myeloid leukemia

  2015cites this paper
• Human natural killer cell development in secondary lymphoid tissues.

  2014cites this paper
• Axl as a mediator of cellular growth and survival

  2014influential citation
• Location and cellular stages of natural killer cell development.

  2013cites this paper